Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foote

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Trends in Ecology & Evolution|January 18, 2011
Descriptive and predictive approaches to biodiversity measurement Reply from M. Foote and K. RoyM Foote, K Roy
Journal of Hematotherapy & Stem Cell Research|December 20, 1999
Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infectionM Foote, W Welch
Journal of Hematotherapy & Stem Cell Research|December 20, 1999
The use of Filgrastim in AIDS-related neutropeniaW Welch, M Foote
Trends in Ecology & Evolution|January 18, 2011
Morphological approaches to measuring biodiversityK Roy, M Foote
Current Opinion in Biotechnology|December 1, 1995
The new generation of recombinant human hematopoietic cytokinesP Hunt, M Foote
Nature|September 7, 2001
Absolute measures of the completeness of the fossil recordM Foote, J J Sepkoski
Cytokines, Cellular & Molecular Therapy|September 8, 2000
Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesisT A Neumann, M Foote
Science (New York, N.Y.)|December 11, 1992
Cambrian and recent morphological disparityM Foote, S J Gould
Issue Brief (George Washington University. National Health Policy Forum)|November 11, 1999
Physician organizations assuming risk: market and policy implicationsS M Foote, L Sprague
Health Affairs (Project Hope)|August 5, 2000
Increasing use of new prescription drugs: a case studyS M Foote, L Etheredge
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Trends in Ecology & Evolution|January 18, 2011
Descriptive and predictive approaches to biodiversity measurement Reply from M. Foote and K. RoyM Foote, K Roy
Journal of Hematotherapy & Stem Cell Research|December 20, 1999
Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infectionM Foote, W Welch
Journal of Hematotherapy & Stem Cell Research|December 20, 1999
The use of Filgrastim in AIDS-related neutropeniaW Welch, M Foote
Trends in Ecology & Evolution|January 18, 2011
Morphological approaches to measuring biodiversityK Roy, M Foote
Current Opinion in Biotechnology|December 1, 1995
The new generation of recombinant human hematopoietic cytokinesP Hunt, M Foote
Nature|September 7, 2001
Absolute measures of the completeness of the fossil recordM Foote, J J Sepkoski
Cytokines, Cellular & Molecular Therapy|September 8, 2000
Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesisT A Neumann, M Foote
Science (New York, N.Y.)|December 11, 1992
Cambrian and recent morphological disparityM Foote, S J Gould
Issue Brief (George Washington University. National Health Policy Forum)|November 11, 1999
Physician organizations assuming risk: market and policy implicationsS M Foote, L Sprague
Health Affairs (Project Hope)|August 5, 2000
Increasing use of new prescription drugs: a case studyS M Foote, L Etheredge
Pageof 16